ClinicalTrials.Veeva

Menu

Does Notch Regulate Glioma Proliferation ? (GLIONOTCH)

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Completed

Conditions

Glioma

Study type

Observational

Funder types

Other

Identifiers

NCT04809597
RECHMPL21_0172

Details and patient eligibility

About

The investigators showed in 2015 (Guichet et al) that the Notch1 pathway has an anti-proliferative role on glial brain tumors. In this project, the investigators investigated which genes downstream of Notch1 pathway activation produce the anti-proliferative effect. The investigators hypothesized that the SNAI2 and TAL1 genes act downstream of Notch1

Full description

Main objectives:

To examine the expression of TAL1 and SNAI2 in protein extracts and glioma sections of different grades (glioblastomas and diffuse low-grade tumors).

To examine the effect of overexpression of Tal1 and Snai2 in high grade glioma cultures.

To show the expression of Tal1 and SNAI2 by tumor cells by FISH technique. Show that TAL1 and SNAI2 could be regulated by endothelial cells

Enrollment

10 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient ≥18 years old
  • Patient affected with brain glioma classified according to WHO 2016 classification

Exclusion criteria

  • Patient who reject the study protocol
  • Radiotheray or chemotherapy treatment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems